Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Jan 18, 2006

30339_dirs_2006-01-18_ab448804-189e-48e2-a40c-2384405a4930.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-01-13

Reporting Person: ALTEMUS LINDA R (VP & Chief Compliance Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2006-01-13 Common stocks A 10.79 $28.2200 Acquired 4539.3140 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common stocks 22076.4996 Direct
Common stocks 1392.5278 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.